Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
How Peter Marks' FDA Departure Is Impacting Pharma, Biotech Stocks
Merck Highlights Phase 3 ZENITH Trial Evaluating WINREVAIR; Says Trial Stopped Early Due To 'Overwhelming Efficacy Demonstrated in the Primary Endpoint'
Vaxcyte Plans To Drop Developing One Pneumococcal Conjugate Vaccine
Exact Sciences Reports Launch Of Cologuard Plus Colorectal Cancer Screening Test
What kind of week will this be? Global stock markets are facing a "tariff storm," and U.S. Treasury bonds are back in focus.
Since this quarter, U.S. Treasury bonds have outperformed Stocks, with a cumulative increase of more than 2%, while the S&P 500 Index has declined by about 5%. Analysis suggests that the 'reciprocal tariff' policy may impact the stock of Industries such as Autos, chips, and Pharmaceuticals, while the outlook of economic downturn and declining stock market will continue to elevate U.S. Treasury bonds as a safe haven Assets.
SA Asks: What Are the Best Large-cap Cardiology Stocks Right Now?